Base bibliographique

Résumé des communications d'onco-urologie présentées au 101 e Congrès de l'Association française d'urologie
- Réf : Prog Urol, 2008, 18, 31-37, suppl. 1002


Regarding renal cell carcinoma, most recent advances concern metastatic cases in which antiangiogenic agent seem to be efficient for specific survival and outcome without progression of the disease. In prostate cancer, new urinary molecular markers, more specific than PSA, are currently under development to allow an early and non invasive diagnosis of the disease. Robot-assisted radical prostatectomy is a growing surgical approach in the treatment of localized prostate cancer, at the expense of the laparoscopic approach, with satisfactory oncologic preliminary results. Whether or not a cystectomy should be done after the resection of a pT1G3 bladder tumour, remains a moot point. However the risk of progression is far from being negligible. Regarding upper urinary tract tumors, the outcome is different from bladder tumors and several teams are working on specific molecular markers, dedicated to be useful in prognosis and specific survival.

Résumé des communications d'urologie fonctionnelle présentées au 101 e Congrès de l'Association française d'urologie
- Réf : Prog Urol, 2008, 18, 25-30, suppl. 1002


Functional urology knows more and more a marked development. Regarding benign prostatic hypertrophia, combined treatments are used often and new molecules such as inhibitor of phosphodiesterase of type 5 are appearing. The gold standard treatment of urinary incontinence with sphincteric deficiency remains the artificial urinary sphincter, in men and in women, where the rate of success is nearly of 95 %. The use of botulic toxin in neurogenic bladder and especially in overactive bladder is growing remarkably, notably in patients of whom quality of life is improve against a very low toxicity. However, the effect of the molecules becomes blurred within a few months. The CT diagnosis of urinary lithiasis is about to provide nowadays the main component of each calculi. Peyronie’s disease remains scarce in which verapamil’s injections are strongly suggested to amend pain but not the curve during erection.